Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin in the Management of Acute Coronary Syndromes Peter J. Zed OriginalPaper Pages: 79 - 87
Platelet PlA2 Polymorphism and Thromboembolic Events: From Inherited Risk to Pharmacogenetics Pascal J. Goldschmidt-ClermontChristine M. RoosGlen E. Cooke OriginalPaper Pages: 89 - 103
Clinical Implications of Elevated PAI-1 Revisited: Multiple Arterial Thrombosis in a Patient with Essential Thrombocythemia and Elevated Plasminogen Activator Inhibitor-1 (PAI-1) Levels with a Review of the Literature Sandra L. SennoLiberto Pechet OriginalPaper Pages: 105 - 112
Coronary Angioplasty or Intravenous Thrombolysis: The Dilemma of Optimal Reperfusion in Acute Myocardial Infarction: A Critical Review of the Literature. Guy AmitA. Teddy WeissDoron Zahger OriginalPaper Pages: 113 - 121
Ischemic Preconditioning May Be Transferable via Whole Blood Transfusion: Preliminary Evidence Eric W. DicksonChristopher P. ReinhardtStephen O. Heard OriginalPaper Pages: 123 - 129
Argatroban Increases Nitric Oxide Levels in Patients with Peripheral Arterial Obstructive Disease: Placebo-Controlled Study Yukitaka UekiKazunari MatsumotoKatsumi Eguchi OriginalPaper Pages: 131 - 137
Venous Thromboembolism Occurs Frequently in Patients Undergoing Brain Tumor Surgery Despite Prophylaxis Andrew T. ChanAndrew AtiemoSamuel Z. Goldhaber OriginalPaper Pages: 139 - 142
Saruplase Is a Safe and Effective Thrombolytic Agent; Observations in 1698 Patients: Results of the PASS Study F. VermeerI. BöslH. Barth OriginalPaper Pages: 143 - 150